Overview of the Global Amlodipine Besylate Market: Amlodipine Besylate is the besylate salt derived from amlodipine. With a molecular weight of 567.1 g/mol and an empirical formula of C20H25CIN2O5•C6H6O3S, it exhibits limited solubility in Ethanol and slight solubility in water. Amlodipine, available as a generic drug, is a Calcium channel blocker (mesylate, besylate, or maleate) known for its antianginal and antihypertensive properties. Approved for medical use in 1990, it is primarily used to treat coronary artery disease and high blood pressure, effectively reducing blood pressure and aiding heart function.
Amlodipine Besylate Tablet Composition and Characteristics: Amlodipine besylate tablets consist of active and inactive ingredients, including dibasic Calcium Phosphate anhydrous, microcrystalline cellulose, Magnesium Stearate, and sodium starch glycolate. These tablets are characterized by their white, biconvex, circular shape, and plain surfaces. Available in 2.5 mg, 5 mg, and 10 mg variants, amlodipine is proven to be safe and effective in treating angina, associated with reduced blood flow to the heart.
Get a sample copy of the Amlodipine Besylate Market report: https://www.reportsanddata.com/download-free-sample/3752
Dynamics of the Global Amlodipine Besylate Market: Amlodipine functions by relaxing blood vessels, thereby lowering blood pressure and reducing the risk of heart attacks, strokes, and kidney problems. Given the high global incidence of heart diseases, there exists a significant demand for amlodipine besylate. Healthcare providers adjust dosage based on patients’ medical history, including heart attack, stroke, cardiac arrest, or stroke.
Amlodipine’s primary application lies in treating hypertension, which stems from various factors such as smoking, diabetes, obesity, lack of physical activity, vitamin D deficiency, stress, and high salt or alcohol intake. With approximately 1.13 billion individuals globally suffering from hypertension, particularly in middle and low-income countries, the demand for amlodipine besylate is anticipated to surge.
While amlodipine offers therapeutic benefits, it also entails certain side effects, including stomach pain, nausea, hypotension, increased angina or myocardial infarction, dizziness, drowsiness, and liver problems. Additionally, alternative medications like clevidipine, nicardipine, and nifedipine pose competition in the market, potentially impeding growth.
Regional Outlook of the Global Amlodipine Besylate Market: The Asia Pacific region, witnessing economic development and an aging population with changing lifestyles and dietary habits, experiences a rise in hypertension cases. Consequently, the market for amlodipine besylate expands alongside the growing hypertensive patient population in the region.
Competitive Landscape in the Global Amlodipine Besylate Market: Ro, a telehealth startup, extends its collaboration with Pfizer to offer generic versions of commonly prescribed cholesterol and blood pressure medications, including Norvasc (a prominent brand of amlodipine besylate). This partnership aims to make Pfizer-produced generics accessible through Ro’s virtual mail-order pharmacy at a competitive price.
Key players in the amlodipine besylate market include Pfizer, Mylan, Reddy’s Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma, Upsher-Smith Laboratories, InvaGen Pharmaceuticals, Sun Pharmaceutical, Aurobindo Pharma, Lupin Pharmaceuticals, Zydus Pharmaceuticals, Oxford Pharm, Wockhardt, Epic Pharma, CR Pharmaceutical, Alkem Laboratories, and MACLEODS.
Report Highlights of the Global Amlodipine Besylate Market: The report provides a detailed overview of the amlodipine besylate market, highlighting its changing dynamics, segmentation, regional landscape, historical and projected market data in terms of volume and value, recent trends, developments, and competitive strategies adopted by key players. Additionally, it presents market segmentation based on type (5 mg, 10 mg tablets) and application (high blood pressure, heart diseases).
Explore Trending Reports:
Industrial Coatings Market-https://www.reportsanddata.com/report-detail/industrial-coatings-market
Trivalent Chromium Finishing Market-https://www.reportsanddata.com/report-detail/trivalent-chromium-finishing-market
Cosmetic Chemicals Market-https://www.reportsanddata.com/report-detail/cosmetic-chemicals-market
Coating Additives Market-https://www.reportsanddata.com/report-detail/coating-additives-market
Pigment Dispersion Market-https://www.reportsanddata.com/report-detail/pigment-dispersion-market
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/3752
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
